CAR-T therapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

CAR-T therapy
Jun 22, 2025, 10:35 | Insight
Yan Leyfman Highlighted Science Study on In Vivo CAR-T Cell Generation for Cancer and Autoimmune Disease
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Breakthrough…
Jun 12, 2025, 14:10 | Insight
Yan Leyfman: Breakthrough in Solid Tumor CAR T Therapy
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Breakthrough…
Jun 1, 2025, 14:52 | Insight
Key Insights by Tom Powles from ASCO25
The ASCO Annual Meeting 2025 is now in full swing in Chicago! From May 30…
May 6, 2025, 15:11 | Blog
Highlights from the 4th POEM Group Scientific Meeting in Amman
From May 1–3, 2025, Amman, Jordan hosted the 4th Scientific Meeting of the Pediatric Oncology…
Apr 4, 2025, 10:24 | Science
Yan Leyfman: InflaMix predicts CAR-T failure in Non-Hodgkin Lymphoma patients
Yan Leyfman, Co-founder and executive director of MedNews Week, shared an article by Sandeep S. Raj, et…
Apr 1, 2025, 12:48 | Science
Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL
Yan Leyfman, Co-founder and executive director of MedNews Week, shared an article by Nirav N.…
Mar 30, 2025, 13:41 | Blog
Yan Leyfman: Advancing CAR-T Therapy for Solid Tumors
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Advancing…
Mar 18, 2025, 14:49 | Science
Yan Leyfman: New study challenges the 8-week driving restriction for patients receiving CAR-T therapy for MM
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn about…
Mar 17, 2025, 09:24 | Science
Myeloma Paper of the Day, March 17th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Mar 10, 2025, 09:12 | Science
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Jan 28, 2025, 07:02 | Science
Innovation in Cancer Treatment at Clinic Barcelona Comprehensive Cancer Center
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a…
Jan 22, 2025, 15:19 | Science
Francisco Conesa Buendía: Off-the-Shelf Cancer Immunotherapy - A Deep Dive into AlloCAR-NKT Cells
Francisco Conesa Buendía, Assistant of Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Jan 6, 2025, 16:35 | Science
Francisco Conesa Buendia: Advancing CAR-T Therapy for Solid Tumors - Breaking Barriers with Innovation
Francisco Conesa Buendía, Assistant in Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Dec 31, 2024, 11:27 | Insight
Rafael Madero Marroquín: CD58 loss as a mechanism of resistance to blina and CAR-T therapy
Rafael Madero Marroquín, Hematology Oncology Fellow at The University of Chicago Medical Center, shared on…
Dec 25, 2024, 14:43 | Science
Rachit Khandelwal: P-I-M with CD19 CAR-T therapy linked to reduced survival in hematologic malignancies
Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, Gurgaon, posted on X: "Four weeks…
Dec 24, 2024, 11:33 | Blog
Muhammad Umair Mushtaq: Utilizing CAR-T therapy in relapsed/refractory multiple myeloma
Muhammad Umair Mushtaq, Associate Professor of Medicine at University of Kansas Medical Center, shared a…
Dec 23, 2024, 14:07 | Blog
Rahul Gosain: Toxicity Check on Chimeric Antigen Receptor T-Cell Therapy
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared…
Dec 21, 2024, 22:26 | Blog
Anas Younes: Transforming outcomes for people living with Blood Cancer
Anas Younes, Senior VP, Global Head of Hematology (Early and Late Stage), Oncology R&D at…
Dec 18, 2024, 10:30 | Blog
Nicholas Restifo: A Breakthrough Year for T Cells
Nicholas Restifo, Co-founder and Chief Scientist at Marble Therapeutics, shared on LinkedIn: “A Breakthrough Year…
Dec 14, 2024, 13:59 | Insight
ASH: Monoclonal antibody therapy improves survival in cancer-associated hyper-inflammatory disorder
ELA026 Shows Promising Results in Phase Ib Trial for Malignancy-Associated HLH. MD Anderson Researchers Report…
Dec 12, 2024, 16:42 | Blog
Laura Korin: Gloria Iacoboni on site specific outcomes of CAR-T therapy
Laura Korin, Doctor of the Haematology Service and Unit Of Haematopoietic Transplantation (UTH) of the…
Dec 12, 2024, 13:21 | Blog
Shivani Modi: That's a wrap on ASH 2024!
Shivani Modi, Resident Physician at Jefferson Health, posted on X: "That's a wrap on ASH24!…
Nov 15, 2024, 17:47 | Blog
Nico Gagelmann: Current status and Future directions for CAR-T Therapy
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a post on X: "Chimeric antigen receptor T…
Oct 17, 2024, 09:43 | Insight
Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc., a biotechnology firm focused on cancer treatment and prevention, has announced the…
Oct 7, 2024, 15:11 | Blog
An innovative CAR-T therapy with promising results - NCIS
National University Cancer Institute, Singapore (NCIS) shared on LinkedIn: "Our doctors have developed an innovative…
Sep 14, 2024, 14:02 | Blog
Amol Akhade: Advanced cell therapy for solid tumors - Where do we stand?
Amol Akhade posted the following on LinkedIn: “I don’t know who should know this more…
Sep 2, 2024, 18:35 | Blog
Dr. Owen O'Connor: The Vessel of Hope for Peripheral T-Cell Lymphoma Braves the Storm and Forges Ahead Fearlessly
MediaMedic made the following blog on LinkedIn: "In order to further improve the diagnostic and treatment…
Aug 23, 2024, 06:22 | Blog
Highlights from the 2024 Seattle Cellular Therapy Summit
The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…
Aug 9, 2024, 05:13 | Insight
Krishna Komanduri: CMV reactivation after CAR-T therapy for lymphoma
Recently, an article by Rick Lin et al. titled "Incidence and outcomes of cytomegalovirus reactivation…
Jul 27, 2024, 13:23 | Insight
Myeloma Paper of the Day, July 27th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study of molecular mechanisms promoting long-term…
Jul 24, 2024, 02:33 | Insight
Hope in CAR-T Therapy: Promising Results in Incurable Pediatric Brain Cancer
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn…
Jul 7, 2024, 06:54 | Insight
Olivier Saulnier: Cellular origins of medulloblastoma
Olivier Saulnier, Junior Group Leader at Institut Curie, made the following post on X: "Excited…
Jun 27, 2024, 10:31 | Blog
Sanjay Juneja: This is probably my most-proud video
Sanjay Juneja, Hematologist and Medical Oncologist at Mary Bird Perkins Cancer Center, shared on LinkedIn:…
Jun 24, 2024, 22:40 | Insight
Mehdi Hamadani: Outpatient administration of every single commercial CAR-T product
Mehdi Hamadani, Director of the BMT and Cellular Therapy Program at the Medical College of…
Jun 18, 2024, 14:43 | Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 12, 2024, 14:11 | Insight
Maria Hendricks: CAR-T therapy is considered a cure for some types of cancer
Maria Hendricks, Director of Clinical Research Operations for the Abramson Cancer Center (ACC) Clinical Research…
Jun 2, 2024, 22:16 | Insight
ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Clinical trial results suggest new treatment options could reduce need for stem cell transplants and…
May 20, 2024, 07:05 | Blog
Marcela Maus: Expanding our clinical research around CAR-T therapy
Marcela Maus, Director of Cellular Immunotherapy, MGH Cancer Center Associate Professor at Harvard Medical School,…
May 13, 2024, 08:08 | Blog
Monica Bertagnolli: Fascinating research I recently read about CAR-T therapy
Monica Bertagnolli shared a post on LinkedIn: ''Fascinating research I recently read about in the New…
May 10, 2024, 15:58 | Blog
Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!
Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn: “Great…
May 10, 2024, 12:08 | Blog
Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!
Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn: "Great…
Apr 26, 2024, 20:41 | Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
All: 42 Posts: 1 - 100
Special Coverage